Inhibition of DDX3X alleviates persistent inflammation, immune suppression and catabolism syndrome in a septic mice model
International Immunopharmacology · 2023-04 · 117 · 109779
DOI: 10.1016/j.intimp.2023.109779 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-04. Verfasst von Yukun Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Chi…. Hauptthemen laut MEDLINE: Sepsis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: DDX3X is involved in various pathological processes such as infection, immunity and cell death. This study aimed to investigate the effect of RK-33, a specific inhibitor of DDX3X, on the progression of sepsis to persistent inflammation, immune suppression and catabolism syndrome(PICS). METHODS: The septic mice model was established using caecal ligation and perforation (CLP). The mice were randomly divided into four groups: sham group, sham + RK-33 group (20 mg/kg, intraperitoneal injection, once a day), CLP group and CLP + RK-33 group (20 mg/kg, intraperitoneal injection, once a day). The number of inflammatory cells in the peripheral blood, spleen and bone marrow was calculated, and inflammatory cytokines were detected using an enzyme-linked immunosorbent assay. The septic mice's body weight and skeletal muscle mass were measured, and skeletal muscle tissues were examined using eosin staining. Western blotting was performed to detect the expression levels of MuRF1, atrogin1 and NLRP3 in the skeletal muscle of septic mice. Additionally, reactive oxidative species, superoxide dismutase and malondialdehyde were measured using commercial kits. RESULTS: RK-33 reduced inflammatory cell counts and cytokine levels in CLP mice, ameliorated the decline in CD4 and CD8 T cells and prevented the loss of body weight and skeletal muscle mass in septic mice. Additionally, RX-33 reduced oxidative stress in the skeletal muscle of septic mice. CONCLUSION: In the established sepsis mouse model, RK-33 alleviated inflammation and oxidative stress, ameliorated CLP-induced immunosuppression and skeletal muscle atrophy and improved survival. These findings suggest that RK-33 could be a novel potential therapeutic agent for preventing the progression of sepsis to PICS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Trauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.
- Trauma Center/Department of Emergency and Traumatic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China. Electronic address: tjwangyuchang@tjh.tjmu.e…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Zhang, Y., Wang, C., Liu, Q., Li, T., Wang, W., Yang, F., Li, Z., Bai, X., & Wang, Y. (2023). Inhibition of DDX3X alleviates persistent inflammation, immune suppression and catabolism syndrome in a septic mice model. International Immunopharmacology, 117, 109779. https://doi.org/10.1016/j.intimp.2023.109779
Vancouver
Liu Y, Zhang Y, Wang C, Liu Q, Li T, Wang W, et al. Inhibition of DDX3X alleviates persistent inflammation, immune suppression and catabolism syndrome in a septic mice model. International Immunopharmacology. 2023;117:109779. doi:10.1016/j.intimp.2023.109779
BibTeX
@article{Liu2023,
author = {Liu, Yukun and Zhang, Yongsheng and Wang, Chuntao and Liu, Qinxin and Li, Tianyu and Wang, Wei and Yang, Fan and Li, Zhanfei and Bai, Xiangjun and Wang, Yuchang},
title = {Inhibition of DDX3X alleviates persistent inflammation, immune suppression and catabolism syndrome in a septic mice model},
journal = {International Immunopharmacology},
year = {2023},
volume = {117},
pages = {109779},
doi = {10.1016/j.intimp.2023.109779}
}
EUVIMED